249 related articles for article (PubMed ID: 30840191)
1. Relative and Absolute Expression Analysis of MicroRNAs Associated with Luminal A Breast Cancer- A Comparison.
Arabkari V; Clancy E; Dwyer RM; Kerin MJ; Kalinina O; Holian E; Newell J; Smith TJ
Pathol Oncol Res; 2020 Apr; 26(2):833-844. PubMed ID: 30840191
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of oncologic miRNA biomarkers for luminal A-like breast cancer.
McDermott AM; Miller N; Wall D; Martyn LM; Ball G; Sweeney KJ; Kerin MJ
PLoS One; 2014; 9(1):e87032. PubMed ID: 24498016
[TBL] [Abstract][Full Text] [Related]
3. Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection.
Schrauder MG; Strick R; Schulz-Wendtland R; Strissel PL; Kahmann L; Loehberg CR; Lux MP; Jud SM; Hartmann A; Hein A; Bayer CM; Bani MR; Richter S; Adamietz BR; Wenkel E; Rauh C; Beckmann MW; Fasching PA
PLoS One; 2012; 7(1):e29770. PubMed ID: 22242178
[TBL] [Abstract][Full Text] [Related]
4. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
[TBL] [Abstract][Full Text] [Related]
5. Cross Platform Standardisation of an Experimental Pipeline for Use in the Identification of Dysregulated Human Circulating MiRNAs.
Kelly H; Downing T; Tuite NL; Smith TJ; Kerin MJ; Dwyer RM; Clancy E; Barry T; Reddington K
PLoS One; 2015; 10(9):e0137389. PubMed ID: 26355751
[TBL] [Abstract][Full Text] [Related]
6. Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer.
McAnena P; Tanriverdi K; Curran C; Gilligan K; Freedman JE; Brown JAL; Kerin MJ
BMC Cancer; 2019 May; 19(1):436. PubMed ID: 31077182
[TBL] [Abstract][Full Text] [Related]
7. Serum circulating microRNA profiling for identification of potential breast cancer biomarkers.
Mar-Aguilar F; Mendoza-Ramírez JA; Malagón-Santiago I; Espino-Silva PK; Santuario-Facio SK; Ruiz-Flores P; Rodríguez-Padilla C; Reséndez-Pérez D
Dis Markers; 2013; 34(3):163-9. PubMed ID: 23334650
[TBL] [Abstract][Full Text] [Related]
8. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
9. Small non-coding RNA profiling in breast cancer: plasma U6 snRNA, miR-451a and miR-548b-5p as novel diagnostic and prognostic biomarkers.
Záveský L; Jandáková E; Weinberger V; Minář L; Hanzíková V; Dušková D; Faridová A; Turyna R; Slanař O; Hořínek A; Kohoutová M
Mol Biol Rep; 2022 Mar; 49(3):1955-1971. PubMed ID: 34993725
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
Schaefer A; Jung M; Mollenkopf HJ; Wagner I; Stephan C; Jentzmik F; Miller K; Lein M; Kristiansen G; Jung K
Int J Cancer; 2010 Mar; 126(5):1166-76. PubMed ID: 19676045
[TBL] [Abstract][Full Text] [Related]
11. Robust expression of tumor suppressor miRNA's let-7 and miR-195 detected in plasma of Saudi female breast cancer patients.
Qattan A; Intabli H; Alkhayal W; Eltabache C; Tweigieri T; Amer SB
BMC Cancer; 2017 Nov; 17(1):799. PubMed ID: 29183284
[TBL] [Abstract][Full Text] [Related]
12. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
[TBL] [Abstract][Full Text] [Related]
13. Absolute Quantification of Plasma MicroRNA Levels in Cynomolgus Monkeys, Using Quantitative Real-time Reverse Transcription PCR.
Iguchi T; Niino N; Tamai S; Sakurai K; Mori K
J Vis Exp; 2018 Feb; (132):. PubMed ID: 29553521
[TBL] [Abstract][Full Text] [Related]
14. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases.
Xiong DD; Lv J; Wei KL; Feng ZB; Chen JT; Liu KC; Chen G; Luo DZ
Oncol Rep; 2017 Jun; 37(6):3297-3304. PubMed ID: 28440475
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of miRNA-9 and miRNA-34a as potential biomarkers for diagnosis of breast cancer in Iranian women.
Orangi E; Motovali-Bashi M
Gene; 2019 Mar; 687():272-279. PubMed ID: 30468908
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA Expression Profiling to Identify and Validate Reference Genes for the Relative Quantification of microRNA in Rectal Cancer.
Eriksen AH; Andersen RF; Pallisgaard N; Sørensen FB; Jakobsen A; Hansen TF
PLoS One; 2016; 11(3):e0150593. PubMed ID: 26937645
[TBL] [Abstract][Full Text] [Related]
18. Identification of miRNAs Enriched in Extracellular Vesicles Derived from Serum Samples of Breast Cancer Patients.
Ozawa PMM; Vieira E; Lemos DS; Souza ILM; Zanata SM; Pankievicz VC; Tuleski TR; Souza EM; Wowk PF; Urban CA; Kuroda F; Lima RS; Almeida RC; Gradia DF; Cavalli IJ; Cavalli LR; Malheiros D; Ribeiro EMSF
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31963351
[TBL] [Abstract][Full Text] [Related]
19. Circulating microRNAs in plasma as early detection markers for breast cancer.
Cuk K; Zucknick M; Heil J; Madhavan D; Schott S; Turchinovich A; Arlt D; Rath M; Sohn C; Benner A; Junkermann H; Schneeweiss A; Burwinkel B
Int J Cancer; 2013 Apr; 132(7):1602-12. PubMed ID: 22927033
[TBL] [Abstract][Full Text] [Related]
20. Small nucleolar RNA U91 is a new internal control for accurate microRNAs quantification in pancreatic cancer.
Popov A; Szabo A; Mandys V
BMC Cancer; 2015 Oct; 15():774. PubMed ID: 26499892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
